Shereen M. EL‐Maghraby

Importance of serum IL-18 and RANTES as markers for breast carcinoma progression.

Soheir Abdel Latif Eissa, Samar A Zaki, Shereen M. EL‐Maghraby et al. · PubMed · 2005 · 76 citations

Medicine, Immunology, Oncology +17

The Diagnostic Value of C-reactive Protein, Interleukin-8, and Monocyte Chemotactic Protein in Risk Stratification of Febrile Neutropenic Children With Hematologic Malignancies

Shereen M. EL‐Maghraby, Manar M. Moneer, Manar Mohamed Ismail et al. · Journal of Pediatric Hematology/Oncology · 2007 · 59 citations

Medicine, Oncology, Pediatrics +15

Prognostic value of miRNA-155 expression in B-cell Non-Hodgkin's lymphoma

Ahmed M. Bedewy, Shereen M. EL‐Maghraby, Ahmed A. Shehata et al. · Turkish Journal of Hematology · 2017 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?

Ahmed M. Bedewy, Shereen M. EL‐Maghraby · Hematology · 2013 · 24 citations

Medicine, Genetics, Molecular Genetics +14

Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.

Ahmed M. Bedewy, M. H. Mostafa, A.A. Saad et al. · PubMed · 2013 · 19 citations

Medicine, Genetics, Molecular Genetics +11